X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (175) 175
Book Chapter (5) 5
Patent (5) 5
Publication (5) 5
Magazine Article (4) 4
Book / eBook (2) 2
Conference Proceeding (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
ophthalmology (124) 124
humans (123) 123
female (91) 91
male (84) 84
aged (83) 83
fluorescein angiography (61) 61
aged, 80 and over (54) 54
middle aged (54) 54
macular degeneration (47) 47
visual acuity (42) 42
treatment outcome (38) 38
indocyanine green (36) 36
index medicus (34) 34
macular degeneration - complications (34) 34
adult (31) 31
retrospective studies (31) 31
choroid - blood supply (29) 29
fundus oculi (29) 29
tomography, optical coherence (27) 27
choroidal neovascularization - drug therapy (26) 26
choroidal neovascularization - etiology (26) 26
visual acuity - physiology (26) 26
choroidal neovascularization (24) 24
follow-up studies (24) 24
ranibizumab (24) 24
neovascularization (23) 23
photochemotherapy (22) 22
bevacizumab (20) 20
macular degeneration - drug therapy (20) 20
prospective studies (20) 20
angiogenesis inhibitors - therapeutic use (19) 19
photosensitizing agents - therapeutic use (18) 18
porphyrins - therapeutic use (18) 18
age-related macular degeneration (17) 17
photodynamic therapy (17) 17
double-blind method (16) 16
coloring agents (15) 15
angiography (14) 14
choroidal neovascularization - diagnosis (14) 14
intravitreal injections (14) 14
vascular endothelial growth factor a - antagonists & inhibitors (14) 14
verteporfin (14) 14
fluorescein angiography - methods (13) 13
injections (13) 13
neovascularization, pathologic - diagnosis (13) 13
neovascularization, pathologic - etiology (13) 13
physiological aspects (13) 13
retina (13) 13
video recording (13) 13
fovea centralis (12) 12
macular degeneration - diagnosis (12) 12
vascular endothelial growth factor (12) 12
vitreous body (12) 12
safety (11) 11
angiogenesis inhibitors - administration & dosage (10) 10
angiogenesis inhibitors - adverse effects (10) 10
antibodies, monoclonal, humanized (10) 10
care and treatment (10) 10
choroid - pathology (10) 10
consulting services (10) 10
retinal diseases - diagnosis (10) 10
retinopathy (10) 10
therapy (10) 10
analysis (9) 9
endothelial growth-factor (9) 9
eye (9) 9
indocyanine green angiography (9) 9
laser coagulation (9) 9
pilot projects (9) 9
wet macular degeneration - diagnosis (9) 9
wet macular degeneration - drug therapy (9) 9
antibodies, monoclonal - therapeutic use (8) 8
macular degeneration - physiopathology (8) 8
receptors, vascular endothelial growth factor - administration & dosage (8) 8
recombinant fusion proteins - administration & dosage (8) 8
choroid diseases - diagnosis (7) 7
diagnosis, differential (7) 7
drug therapy (7) 7
eye diseases (7) 7
macula (7) 7
neovascularization, pathologic - surgery (7) 7
optical coherence tomography (7) 7
pigment epithelial detachment (7) 7
retinal detachment - diagnosis (7) 7
risk factors (7) 7
steroids (7) 7
abridged index medicus (6) 6
adolescent (6) 6
disease (6) 6
exudates and transudates (6) 6
laser photocoagulation (6) 6
photosensitizing agents - adverse effects (6) 6
porphyrins - adverse effects (6) 6
pregnadienediols - therapeutic use (6) 6
retinal vessels - pathology (6) 6
visual acuity - drug effects (6) 6
vitrectomy (6) 6
age (5) 5
anecortave acetate (5) 5
antibodies, monoclonal - adverse effects (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Ophthalmology, ISSN 0161-6420, 2014, Volume 121, Issue 11, pp. 2247 - 2254
Journal Article
Ophthalmology, ISSN 0161-6420, 01/2014, Volume 121, Issue 1, pp. 193 - 201
Journal Article
Ophthalmology, ISSN 0161-6420, 10/2015, Volume 122, Issue 10, pp. 2044 - 2052
Journal Article
American Journal of Ophthalmology, ISSN 0002-9394, 2009, Volume 147, Issue 2, pp. 298 - 306
Journal Article
Transactions of the American Ophthalmological Society, ISSN 0065-9533, 2015, Volume 113, pp. T9-1 - T9-18
To develop a new diabetic retinopathy severity scoring system and to determine if it can monitor changes from baseline as well as identify precise features... 
Reproducibility of Results | Humans | Middle Aged | Male | Disease Progression | Young Adult | Diabetic Retinopathy - diagnosis | Algorithms | Diagnosis, Computer-Assisted - methods | Macular Edema - diagnosis | Adult | Female | Aged | Ophthalmology | Photography - methods | Diagnostic Techniques, Ophthalmological
Journal Article
Journal Article
Journal Article
JAMA Ophthalmology, ISSN 2168-6165, 07/2017, Volume 135, Issue 7, p. 761
Importance An oral treatment for neovascular age-related macular degeneration would be less burdensome than repeated intravitreous injections. X-82 is an oral... 
Tyrosine | Enzymes | Anorexia | Alanine | Platelet-derived growth factor | Medical treatment | Transaminase | Liver | Diarrhea | Fatigue | Retina | Nausea | Visual perception | Leg | Acuity | Macular degeneration | Eye | Prescription drugs | Alanine transaminase | Vascular endothelial growth factor | Protein-tyrosine kinase | Age
Journal Article
Journal Article
Acta Ophthalmologica, ISSN 1755-375X, 12/2018, Volume 96, Issue 8, pp. e911 - e918
Purpose Identify predictors for response to anti-vascular endothelial growth factor (VEGF) therapy in patients with neovascular (wet) age-related macular... 
neovascular age‐related macular degeneration | predictors | aflibercept | anti‐vascular endothelial growth factor | neovascular age-related macular degeneration | anti-vascular endothelial growth factor | OPHTHALMOLOGY | SUBGROUP ANALYSIS | RANIBIZUMAB | Follow-Up Studies | Intravitreal Injections | Humans | Middle Aged | Male | Wet Macular Degeneration - physiopathology | Dose-Response Relationship, Drug | Angiogenesis Inhibitors - administration & dosage | Time Factors | Receptors, Vascular Endothelial Growth Factor - antagonists & inhibitors | Female | Retrospective Studies | Recombinant Fusion Proteins - administration & dosage | Fluorescein Angiography | Drug Administration Schedule | Tomography, Optical Coherence | Treatment Outcome | Visual Acuity | Macula Lutea - diagnostic imaging | Receptors, Vascular Endothelial Growth Factor - administration & dosage | Wet Macular Degeneration - diagnosis | Wet Macular Degeneration - drug therapy | Ranibizumab - administration & dosage | Aged | Fundus Oculi | Macular degeneration | Diabetic retinopathy | Care and treatment | Patient outcomes | Analysis | Physiological aspects | Neovascularization | Vascular endothelial growth factor | Therapy | Retinopathy | Demography | Diabetes mellitus | Retina | Visual acuity | Patients | Age related diseases | Vascularization | Acuity | Demographics | Vision | Growth factors | Age
Journal Article
Ophthalmology, ISSN 0161-6420, 2015, Volume 122, Issue 1, pp. 138 - 145
Purpose To determine the safety and efficacy of low-voltage, external-beam, stereotactic radiotherapy (SRT) for patients with neovascular age-related macular... 
Ophthalmology | EYE | VITRECTOMY | BEVACIZUMAB | SAFETY | EPIRETINAL BRACHYTHERAPY | OPHTHALMOLOGY | CABERNET | MERITAGE | EPIMACULAR BRACHYTHERAPY | RANIBIZUMAB | Macular degeneration | Physiological aspects | Radiotherapy | Consulting services | Analysis
Journal Article